Dr. William Chey Highlights Unmet Medical Need of Lactose Intolerance and Potential for Phase 3 Drug Candidate RP-G28 in Expert Call Hosted by Ritter Pharmaceuticals

February 28, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search